469 related articles for article (PubMed ID: 22365299)
1. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with embolization and vincristine in two newborns.
Garcia-Monaco R; Giachetti A; Peralta O; Napoli N; Lobos P; Gioseffi L; Mariani G
J Vasc Interv Radiol; 2012 Mar; 23(3):417-22. PubMed ID: 22365299
[TBL] [Abstract][Full Text] [Related]
2. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus.
Jahnel J; Lackner H; Reiterer F; Urlesberger B; Urban C
Klin Padiatr; 2012 Oct; 224(6):395-7. PubMed ID: 23070861
[No Abstract] [Full Text] [Related]
3. Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up.
Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S
Pediatr Blood Cancer; 2015 Apr; 62(4):577-80. PubMed ID: 25346262
[TBL] [Abstract][Full Text] [Related]
4. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
Cashell J; Smink GM; Helm K; Xavier F
Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
[TBL] [Abstract][Full Text] [Related]
5. Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence?
Ji Y; Chen S; Yang K; Xia C; Peng S
J Dermatol; 2018 Oct; 45(10):1203-1206. PubMed ID: 30118141
[TBL] [Abstract][Full Text] [Related]
6. Capillary-lymphatic malformation, kaposiform hemangioendothelioma and delayed Kasabach-Merritt phenomenon.
del Pozo J; López-Gutiérrez JC; Gómez-Tellado M; Nistal M; Soler R; Sacristán F; Tovar JA
Pediatr Dermatol; 2011; 28(4):439-43. PubMed ID: 20403115
[TBL] [Abstract][Full Text] [Related]
7. Giant vascular malformation with thrombocytopenia in a newborn.
Downing A; Chauhan A; Lotterman C; Craver R; Warrier R
Clin Pediatr (Phila); 2013 Nov; 52(11):1079-82. PubMed ID: 24002050
[No Abstract] [Full Text] [Related]
8. Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon.
Fernandez-Pineda I; Lopez-Gutierrez JC; Chocarro G; Bernabeu-Wittel J; Ramirez-Villar GL
Pediatr Blood Cancer; 2013 Sep; 60(9):1478-81. PubMed ID: 23609996
[TBL] [Abstract][Full Text] [Related]
9. Decreased vascularization of retroperitoneal kaposiform hemangioendothelioma induced by treatment with sirolimus explains relief of symptoms.
Iacobas I; Simon ML; Amir T; Gribbin CE; McPartland TG; Kaufman MR; Calderwood S; Nosher JL
Clin Imaging; 2015; 39(3):529-32. PubMed ID: 25662209
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of Kaposiform hemangioendothelioma with everolimus.
Uno T; Ito S; Nakazawa A; Miyazaki O; Mori T; Terashima K
Pediatr Blood Cancer; 2015 Mar; 62(3):536-8. PubMed ID: 25306933
[TBL] [Abstract][Full Text] [Related]
11. Comment on: Steroid-resistant kaposiform hemangioendothelioma: A retrospective study of 37 patients treated with vincristine and long-term follow-up.
Adams DM; Hammill AM; Mobberley-Schuman PS; Trenor CC
Pediatr Blood Cancer; 2015 Nov; 62(11):2056. PubMed ID: 26052679
[No Abstract] [Full Text] [Related]
12. Kaposiform haemangioendothelioma in a nine-year-old boy with Kasabach-Merritt phenomenon.
Zhang G; Gao Y; Liu X
Br J Haematol; 2017 Oct; 179(1):9. PubMed ID: 28714059
[No Abstract] [Full Text] [Related]
13. Kaposiform Hemangioendothelioma Presenting as Hydrops Fetalis.
Sobrino-Fernández E; Campos-Domínguez M; Gregorio-Hernández R; Huerta-Aragonés J; Beléndez-Bieler C; Lancharro-Zapata Á; Franco-Fernández ML; Bernardo-Atienza B; Sánchez-Luna M
Pediatr Dermatol; 2017 May; 34(3):e128-e129. PubMed ID: 28318049
[TBL] [Abstract][Full Text] [Related]
14. Kaposiform hemangioendothelioma: therapeutic efficacy for an enigmatic diagnosis.
Blei F
Pediatr Blood Cancer; 2015 Apr; 62(4):551-2. PubMed ID: 25559734
[No Abstract] [Full Text] [Related]
15. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment.
Hermans DJ; van Beynum IM; van der Vijver RJ; Kool LJ; de Blaauw I; van der Vleuten CJ
J Pediatr Hematol Oncol; 2011 May; 33(4):e171-3. PubMed ID: 21516018
[TBL] [Abstract][Full Text] [Related]
16. Vincristine, actinomycin D, cyclophosphamide chemotherapy resolves Kasabach-Merritt syndrome resistant to conventional therapies.
Fuchimoto Y; Morikawa N; Kuroda T; Hirobe S; Kamagata S; Kumagai M; Matsuoka K; Morikawa Y
Pediatr Int; 2012 Apr; 54(2):285-7. PubMed ID: 22507155
[No Abstract] [Full Text] [Related]
17. Successful management of Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon using vincristine and ticlopidine.
López V; Martí N; Pereda C; Martín JM; Ramón D; Mayordomo E; Jordá E
Pediatr Dermatol; 2009; 26(3):365-6. PubMed ID: 19706115
[TBL] [Abstract][Full Text] [Related]
18. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with vincristine and ticlopidine.
Barabash-Neila R; García-Rodríguez E; Bernabeu-Wittel J; Bueno-Rodríguez I; Ramírez-Villar G; López-Gutierrez JC
Indian J Pediatr; 2012 Oct; 79(10):1386-7. PubMed ID: 22161581
[No Abstract] [Full Text] [Related]
19. Rapidly enlarging "bruise" on the back of an infant. Kaposiform hemangioendothelioma complicated by Kasabach-Merritt syndrome.
Chan S; Cassarino DS
JAMA Dermatol; 2013 Nov; 149(11):1337-8. PubMed ID: 24005816
[No Abstract] [Full Text] [Related]
20. Role of Sirolimus in Advanced Kaposiform Hemangioendothelioma.
Oza VS; Mamlouk MD; Hess CP; Mathes EF; Frieden IJ
Pediatr Dermatol; 2016; 33(2):e88-92. PubMed ID: 26864138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
